美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Orexigen Therapeutics

0.2229

0.0000

成交量：- -

成交額：- -

市值：420.99萬

市盈率：-0.02

高：0.2229

開：0.2229

低：0.2229

收：0.2229

52周最高：3.81

52周最低：0.1708

股本：1,888.70萬

流通股本：967.74萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-9.7006

淨資產收益率：--

總資產收益率：--

市淨率：-0.07

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Orexigen Therapeutics

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.orexigen.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Orexigen Therapeutics, Inc.於2002年9月在特拉華成立。Orexigen治療股份有限公司是一家生物製藥公司，專註於發展治療肥胖的候選醫藥產品。公司的主導產品有針對肥胖者的已完成三期臨床試驗的納曲酮和已完成二期臨床試驗的empati。納曲酮是兩個行之有效的藥物的組合，包括安非他酮，納曲酮。安非他酮是一種廣泛應用的抗抑鬱藥和戒煙藥物；納曲酮用於酒精和阿片成癮治療。Empatic的組合是安非他酮和唑尼沙胺，唑尼沙胺立即釋放製劑在美國被批准用於部分癲癇發作的輔助治療。每個候選產品在商業化之前都將獲得監管機構的批准。公司在努力的向監管機構證明這些組合的療效和安全性，以獲得批准。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OREX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OREX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OREX\",,,,,undefined,":{"symbol":"OREX","market":"US","secType":"STK","nameCN":"Orexigen Therapeutics","latestPrice":0.2229,"timestamp":1522785600000,"preClose":0.2229,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":9677447,"shares":18887033,"eps":-9.700626,"marketStatus":"退市","change":0,"latestTime":"02-25 04:26:45 EST","open":0.2229,"high":0.2229,"low":0.2229,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-9.700626,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772029800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1177560000000,"exchange":"NASDAQ","adjPreClose":0.2229,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OREX\",,,,,undefined,":{"symbol":"OREX","floatShares":9677447,"roa":"--","roe":"--","lyrEps":0,"shares":18887033,"dividePrice":0,"high":0.2229,"amplitude":0,"preClose":0.2229,"low":0.2229,"week52Low":0.1708,"pbRate":"-0.07","week52High":3.805,"institutionHeld":0.9018,"latestPrice":0.2229,"eps":-9.700626,"divideRate":0,"volume":0,"delay":0,"ttmEps":-9.700626,"open":0.2229},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OREX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-11-13","symbol":"OREX","fiscalQuarterEnding":"2017/09","expectedEps":-2.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1510549200000,"reportTimeType":"post","actualEps":-1.35},{"market":"US","date":"2017-08-08","symbol":"OREX","fiscalQuarterEnding":"2017/06","expectedEps":-2.4,"name":null,"time":"盤後","type":"earning","dateTimestamp":1502164800000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2017-05-09","symbol":"OREX","fiscalQuarterEnding":"2017/03","expectedEps":-2.6,"name":null,"time":"盤後","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"post","actualEps":-4.67},{"market":"US","date":"2017-03-28","symbol":"OREX","fiscalQuarterEnding":"2016/12","expectedEps":-0.54,"name":null,"time":"盤前","type":"earning","dateTimestamp":1490673600000,"reportTimeType":"pre","actualEps":-2.67},{"market":"US","date":"2016-11-03","symbol":"OREX","fiscalQuarterEnding":"2016/09","expectedEps":-2.13,"name":null,"time":"盤後","type":"earning","dateTimestamp":1478145600000,"reportTimeType":"post","actualEps":-1.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OREX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OREX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.orexigen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Orexigen Therapeutics, Inc.於2002年9月在特拉華成立。Orexigen治療股份有限公司是一家生物製藥公司，專註於發展治療肥胖的候選醫藥產品。公司的主導產品有針對肥胖者的已完成三期臨床試驗的納曲酮和已完成二期臨床試驗的empati。納曲酮是兩個行之有效的藥物的組合，包括安非他酮，納曲酮。安非他酮是一種廣泛應用的抗抑鬱藥和戒煙藥物；納曲酮用於酒精和阿片成癮治療。Empatic的組合是安非他酮和唑尼沙胺，唑尼沙胺立即釋放製劑在美國被批准用於部分癲癇發作的輔助治療。每個候選產品在商業化之前都將獲得監管機構的批准。公司在努力的向監管機構證明這些組合的療效和安全性，以獲得批准。","exchange":"NASDAQ","name":"Orexigen Therapeutics","nameEN":"Orexigen Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OREX\",market:\"US\",,,undefined,":null}}